1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | May 2026 | |
|---|---|---|
| Revenue | 748.91K | 16.26% |
| Gross profit | -127.73K | 114.28% |
| Net profit | -874.81K | 172.02% |
| EBITDA | -1.25M | 591.82% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €24.94M |
Number of shares | 80.81M |
52-week high/low | €0.66 - €0.18 |
| Dividends | No |
Beta | 1.33 |
P/E ratio | -8.57 |
PEG ratio | 0.09 |
P/B ratio | 11.56 |
P/S ratio | 5.37 |
Company profile
Telescope Innovations Corp. ist ein chemisches Technologieunternehmen, das sich mit der Entwicklung synthetischer Verfahren für den Zugang zu Arzneimitteln für die Behandlung psychischer Erkrankungen befasst. Der Hauptsitz des Unternehmens befindet sich in Vancouver, Kanada.
| Name | Telescope Innovations Corp. |
| CEO | Henry Dubina |
| Headquarters | Vancouver,
bc Canada |
| Website | |
| Sector | Health Care |
| Industry | Biotechnology |
| IPO | 10/19/2021 |
| Employees | 5 |
Discover assets
Shareholders of Telescope Innovations Corp. also invest in the following assets
